Discussion of “Surrogate Endpoints in Aids Drug Development: Current Status” by C. Chuang-Stein and R. Demasi

1998 ◽  
Vol 32 (2) ◽  
pp. 453-456 ◽  
Author(s):  
A. Lawrence Gould
Keyword(s):  
Drug Development ◽  
Current Status ◽  
Surrogate Endpoints

Surrogate Endpoints in Aids Drug Development: Current Status

1998 ◽  
Vol 32 (2) ◽  
pp. 439-448 ◽  
Author(s):  
Christy Chuang-Stein ◽  
Ralph Demasi
Keyword(s):  
Drug Development ◽  
Current Status ◽  
Surrogate Endpoints

Application of Machine Learning in Drug Development and Regulation: Current Status and Future Potential

2020 ◽  
Vol 107 (4) ◽  
pp. 726-729 ◽  
Author(s):  
Qi Liu ◽  
Hao Zhu ◽  
Chao Liu ◽  
Daphney Jean ◽  
Shiew‐Mei Huang ◽  
...  
Keyword(s):  
Machine Learning ◽  
Drug Development ◽  
Current Status ◽  
Future Potential

Current Status of Celiac Disease Drug Development

2016 ◽  
Vol 111 (6) ◽  
pp. 779-786 ◽  
Author(s):  
Manida Wungjiranirun ◽  
Ciaran P Kelly ◽  
Daniel A Leffler
Keyword(s):  
Celiac Disease ◽  
Drug Development ◽  
Current Status

The status of the lysophosphatidic acid receptor type 1 (LPA1R)

MedChemComm ◽  
2015 ◽  
Vol 6 (1) ◽  
pp. 13-23 ◽  
Author(s):  
Inés González-Gil ◽  
Debora Zian ◽  
Henar Vázquez-Villa ◽  
Silvia Ortega-Gutiérrez ◽  
María L. López-Rodríguez
Keyword(s):  
Drug Development ◽  
Lysophosphatidic Acid ◽  
Receptor Type ◽  
Current Status ◽  
Acid Receptor ◽  
Lysophosphatidic Acid Receptor ◽  
The Status ◽  
Development Pipeline

The current status of the LPA1receptor and its ligands in the drug development pipeline is reviewed.

scholarly journals Bayesian meta-analytical methods to incorporate multiple surrogate endpoints in drug development process

2015 ◽  
Vol 35 (7) ◽  
pp. 1063-1089 ◽  
Author(s):  
Sylwia Bujkiewicz ◽  
John R. Thompson ◽  
Richard D. Riley ◽  
Keith R. Abrams
Keyword(s):  
Drug Development ◽  
Analytical Methods ◽  
Development Process ◽  
Surrogate Endpoints ◽  
Drug Development Process
Sign in / Sign up

Export Citation Format

Share Document